APOE and triple-A syndrome: To directly determine the role of MMP-12 activity upon AAA formation, we treated Ang II-infused hypercholesterolemic Apoe−/− mice with the phosphinic peptide RXP470.1, which is considered a selective inhibitor of MMP-12 activity [27] (Figure 2A).